Zhongnan Hospital Affiliated to Wuhan University
About Zhongnan Hospital Affiliated to Wuhan University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Zhongnan Hospital Affiliated to Wuhan University
During the past decade, Zhongnan Hospital Affiliated to Wuhan University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
2009-04-01
2013-05-01
Completed
360
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
2010-04-19
2017-11-26
Completed
364
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
2010-06-01
2014-01-01
Completed
378
Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
2012-10-01
2015-10-01
Unknown status
400
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
2012-11-01
2015-03-01
Completed
14,032
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Zhongnan Hospital Affiliated to Wuhan University
According to Clinical.Site data, the most researched conditions in "Zhongnan Hospital Affiliated to Wuhan University" are
"Colorectal Cancer" (2 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Head and Neck Cancer" (1 trials) and "Liver Metastasis" (1 trials). Many other conditions were trialed in "Zhongnan Hospital Affiliated to Wuhan University" in a lesser frequency.
Clinical Trials Intervention Types at Zhongnan Hospital Affiliated to Wuhan University
Most popular intervention types in "Zhongnan Hospital Affiliated to Wuhan University" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "5-fluorouracil-based chemotherapy" (1 trials), "MCLA-129" (1 trials), "Mirvetuximab Soravtansine" (1 trials), "Raltitrexed-based chemotherapy" (1 trials) and "Ropeginterferon alfa-2b" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Zhongnan Hospital Affiliated to Wuhan University
The vast majority of trials in "Zhongnan Hospital Affiliated to Wuhan University" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Zhongnan Hospital Affiliated to Wuhan University
Currently, there are NaN active trials in "Zhongnan Hospital Affiliated to Wuhan University".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Zhongnan Hospital Affiliated to Wuhan University,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Zhongnan Hospital Affiliated to Wuhan University, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".